SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000893220-06-001155
Filing Date
2006-05-12
Accepted
2006-05-12 17:25:11
Documents
6
Period of Report
2006-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q DATED 04/02/2006 w21102e10vq.htm 10-Q 388171
2 EMPLOYMENT AGREEMENT DATED FEBRUARY 10,2006 w21102exv10w67.htm EX-10.67 56382
3 RULE 13A-14(A) CERTIFICATION BY PRESIDENT AND CEO w21102exv31w1.htm EX-31.1 8614
4 RULE 13A-14(A) CERTIFICATION BY CFO w21102exv31w2.htm EX-31.2 8597
5 SECTION 906 CERTIFICATION BY PRESIDENT AND CEO w21102exv32w1.htm EX-32.1 3534
6 SECTION 906 CERTIFICATION BY CFO w21102exv32w2.htm EX-32.2 3492
  Complete submission text file 0000893220-06-001155.txt   470300
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 06836201
SIC: 2834 Pharmaceutical Preparations